For instance, in 2012, Tanaka et al. obtained iPS-DMs from patients affected by chronic infantile neurologic cutaneous and articular syndrome (CINCA), an IL-1β-driven inflammatory disease caused mainly by NLRP3 mutations leading to its constitutive activation. Here, NLRP3 is linked to CINCA syndrome.